Liaoning Chengda Biotechnology Co. Ltd.SSE: 688739

Announcement on Shareholding Reduction Plan for Senior Management Members

May 29, 2026 · Issued by Liaoning Chengda Biotechnology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · May 29, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-shareholding-reduction-plan-for-senior-management-members-24

Release

Announcement on Shareholding Reduction Plan for Senior Management Members

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Liaoning Chengda Biotechnology Co. Ltd. on 6ix

Earlier from Liaoning Chengda Biotechnology

Announcement on Implementation of Dividend Distribution for 2025May 28
Announcement on Resolutions of the 2025 Annual General MeetingMay 13
Announcement on Convening Performance Briefing for 2025 and Q1 2026Apr 29
Announcement on 2025 Annual Profit Distribution PlanApr 21
Announcement on Obtaining the Approval for Supplementary Application for Drugs for the Core Product Freeze-dried Rabies Vaccine (Vero Cells)Apr 18

Later from Liaoning Chengda Biotechnology

Announcement on Progress in Repurchasing Shares through Call AuctionJun 3
Announcement on Progress in Joint Investment with the Controlling Shareholder and Its Wholly-owned Subsidiary and Related Party TransactionsJun 6
Announcement on Implementation Result of Shares Repurchase and Share ChangesJun 12
Announcement on Obtaining Drug Registration Certificate for Quadrivalent Influenza Vaccine (Split Virion) and Passing GMP Compliance Inspection for DrugsJun 17
Announcement on the Influenza Virus Split Vaccine Obtaining Drug Registration Certificate and Passing GMP Compliance InspectionJul 3

All Liaoning Chengda Biotechnology news releases

Follow Liaoning Chengda Biotechnology into a list and get an email when it puts out news.

Follow Liaoning Chengda Biotechnology